The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.

“These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ...

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...

Whatever Elon Musk, the CEO of Tesla and SpaceX, says, dons, or does becomes news. On Christmas Day, the man who is the force ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...